Feedback / Questions
vactosertib (TEW-7197) - National OncoVenture, Theragen Etex
Keytruda (pembrolizumab) - Merck (MSD)
http://clinicaltrials.gov/ct2/show/NCT03844750
Jan 1, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next